These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7888994)

  • 21. Computerized analysis of covalent inhibition kinetics for identification of heart muscle cholinesterase and brain carboxylesterase isoenzymes. Design of differential inhibition assays.
    Chemnitius JM; Dewald K; Kreuzer H; Zech R
    Chem Biol Interact; 1993 Jun; 87(1-3):239-44. PubMed ID: 8343980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetic investigations into the interactions of aprophen with cholinesterases and a carboxylesterase.
    Rush RS; Doctor BP; Wolfe AD
    Biochem Pharmacol; 1986 Dec; 35(23):4167-70. PubMed ID: 3098245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Butyrylcholinesterase, paraoxonase, and albumin esterase, but not carboxylesterase, are present in human plasma.
    Li B; Sedlacek M; Manoharan I; Boopathy R; Duysen EG; Masson P; Lockridge O
    Biochem Pharmacol; 2005 Nov; 70(11):1673-84. PubMed ID: 16213467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-inhibition relationships in the interaction of butyrylcholinesterase with bambuterol, haloxon and their leaving groups.
    Sinko G; Bosak A; Kovarik Z; Simeon-Rudolf V
    Chem Biol Interact; 2005 Dec; 157-158():421-3. PubMed ID: 16429568
    [No Abstract]   [Full Text] [Related]  

  • 25. Slow-binding inhibition of carboxylesterase and other serine hydrolases by chlorodifluoroacetaldehyde.
    Yin H; Jones JP; Anders MW
    Chem Res Toxicol; 1993; 6(5):630-4. PubMed ID: 8292740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. alpha,beta-Dehydrophenylalanine choline esters, a new class of reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase.
    Grigoryan HA; Hambardzumyan AA; Mkrtchyan MV; Topuzyan VO; Halebyan GP; Asatryan RS
    Chem Biol Interact; 2008 Jan; 171(1):108-16. PubMed ID: 17980356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of cholinesterase inhibitors on aryl- and carboxylesterase activity].
    Tonkopiĭ VD
    Ukr Biokhim Zh; 1977; 49(1):57-9. PubMed ID: 867524
    [No Abstract]   [Full Text] [Related]  

  • 28. Alteration of hepatic carboxylesterase activity by soman: inhibition in vitro and enhancement in vivo.
    Castle MC
    Xenobiotica; 1989 Jan; 19(1):115-21. PubMed ID: 2756715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of aging of mipafox-inhibited butyrylcholinesterase.
    Kropp TJ; Richardson RJ
    Chem Res Toxicol; 2007 Mar; 20(3):504-10. PubMed ID: 17323978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carboxylesterase inhibition and potentiation of soman toxicity.
    Cohen SD
    Arch Toxicol; 1981 Nov; 49(1):105-6. PubMed ID: 7053071
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of fasciculin on hydrolysis of neutral and choline esters by butyrylcholinesterase, cobra venom and chicken acetylcholinesterases.
    Durán R; Cerveñansky C; Karlsson E
    Toxicon; 1996 Aug; 34(8):959-63. PubMed ID: 8875783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in plasma carboxylesterase activity: relevance to anticholinesterase sensitivity.
    Overstreet DH; Clement JG; Bruzzone A; Kovaliski J; Schiller GD
    Biochem Pharmacol; 1990 Jun; 39(12):2063-4. PubMed ID: 2353946
    [No Abstract]   [Full Text] [Related]  

  • 33. Modification of the essential amino acids of human pancreatic carboxylic-ester hydrolase.
    Lombardo D
    Biochim Biophys Acta; 1982 Jan; 700(1):67-74. PubMed ID: 7055574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delayed neurotoxicity and other consequences of organophosphate esters.
    Baron RL
    Annu Rev Entomol; 1981; 26():29-48. PubMed ID: 7023372
    [No Abstract]   [Full Text] [Related]  

  • 35. Purification and characterization of carboxylesterases from rat lung.
    Gaustad R; Sletten K; Løvhaug D; Fonnum F
    Biochem J; 1991 Mar; 274 ( Pt 3)(Pt 3):693-7. PubMed ID: 2012599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new selective inhibitor of mouse blood plasma carboxylesterase.
    Rudakova EV; Makhaeva GF; Galenko TG; Aksinenko AY; Sokolov VB; Martynov IV
    Dokl Biochem Biophys; 2013; 449():87-9. PubMed ID: 23657654
    [No Abstract]   [Full Text] [Related]  

  • 37. Adaptation of a dynamic in vitro model with real-time determination of butyrylcholinesterase activity in the presence of cyclosarin and an oxime.
    Worek F; Horn G; Wille T; Thiermann H
    Toxicol In Vitro; 2015 Feb; 29(1):162-7. PubMed ID: 25450746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A butyrylcholinesterase inhibitor produced by Penicillium sp. no. C-81 and its identity with mycelianamide.
    Nagasawa T; Mori N; Tani Y; Ogata K
    J Antibiot (Tokyo); 1976 May; 29(5):526-31. PubMed ID: 956041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural requirements for the inhibition of human monocyte carboxylesterase by organophosphorus compounds.
    Saboori AM; Lang DM; Newcombe DS
    Chem Biol Interact; 1991; 80(3):327-38. PubMed ID: 1954660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of sulphation of phenolic substances by the carboxylesterase inhibitor bis-(p-nitrophenyl)-phosphate in the rat in vivo.
    Koster H; Schlotens E; Mulder GJ
    Biochem Pharmacol; 1979 Sep; 28(17):2685-6. PubMed ID: 518682
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.